News

  • News Archive
14 December 2005

Cobra Biomanufacturing Plc Preliminary Results

16 November 2005

Cobra Further Strengthens Management Team

07 November 2005

Cobra Biomanufacturing PLC and Advaxis, Inc enter a Strategic Collaboration and Long-Term Vaccine Supply Agreement for Listeria Cancer Vaccines

10 October 2005

Year-End Trading Update

10 August 2005

Cobra and Auxilium Announce Extension of Agreement to Manufacture AA4500 for Auxilium Pharmaceuticals, Inc.

21 July 2005

Following Inspection by UK Regulators, Cobra’s Manufacturing Authorisation is extended

30 June 2005

Interim results for the six months ended 31 March 2005

02 June 2005

Cobra Signs Agreement with Introgen Therapeutics for Manufacturing Services

04 May 2005

Cobra Biomanufacturing and Synco Biopartners Form Alliance to Manufacture Plasmid DNA for Phase III Trials and Commercial Supply

15 April 2005

AGM Statement/Trading Update

23 March 2005

Pre-clinical Data Supports Potential of Cobra's Proprietary ORT-VAC Oral Bacterial Vaccine

02 March 2005

Cobra signs agreement with Hawaii Biotech Inc to manufacture two novel protein vaccines against Dengue fever and West Nile disease for US clinical trials

25 February 2005

Cobra signs long term deal with Neovacs SA to supply Phase I clinical trial material for a novel protein active immunization therapy-TNFa Kinoid

18 February 2005

New trial of HIV/AIDS vaccine incorporates Cobra technology

11 February 2005

US deal takes order book to £5.9m

For further information, please contact:

Julian Hanak
Commercial Services
Tel: +44 (0) 1782 714 181

   

 

News Alert

View privacy policy